Malaria News and Research

Latest Malaria News and Research

First results from community HIV testing campaign in Uganda

A clinical study in a remote region of southwest Uganda has demonstrated the feasibility of using a health campaign to rapidly test a community for HIV and simultaneously offer prevention and diagnosis for a variety of other diseases in rural and resource-poor settings of sub-Saharan Africa.

24 Jul 2012

First Edition: July 24, 2012

Today's headlines include news from the campaign season as well as reports from the international AIDS conference currently taking place in Washington, D.C.

24 Jul 2012

BioDiem presents positive findings of their eye disease drug at international conference

Australian infectious disease therapy and vaccine development company BioDiem Ltd (ASX: BDM) today announced positive results from formal studies of its BDM-E eye disease drug, presented over 21 – 22 July at the International Society for Eye Research (ISER) meeting in Berlin, Germany. The ISER convenes leading researchers and clinicians in the area of eye disease.

22 Jul 2012

New CHAIT initiative on development of novel immunological therapeutic interventions

The CHAIT initiative is a public-private partnership focusing on the development of novel immunological therapeutic interventions to achieve a 'functional HIV cure' with the ultimate goal of HIV eradication.

21 Jul 2012

Cipla, DNDi to develop ARV combination therapy for children with HIV/AIDS

On the eve of the XIX International AIDS Conference in Washington, DC, the Drugs for Neglected Diseases initiative (DNDi), a not-for-profit research and development (R&D) organization, announces a new collaboration with Indian drug manufacturer Cipla to develop and produce an improved first-line antiretroviral (ARV) combination therapy specifically adapted to meet the treatment needs of infants and toddlers living with HIV/AIDS.

21 Jul 2012

Examining challenges facing Global Fund during its reform

Optimism surrounding the science of HIV treatment and prevention "is tempered by less auspicious trends, particularly shrinking budgets for global health in the U.S. and around the world," Victoria Fan, Amanda Glassman, and Rachel Silverman of the Center for Global Development (CGD) write in the center's "Global Health Policy" blog.

20 Jul 2012

Keystone Symposia on Molecular and Cellular Biology receives Gates Foundation grant

Keystone Symposia on Molecular and Cellular Biology is pleased to announce that it has received a fourth grant from the Bill & Melinda Gates Foundation to promote discoveries that will solve urgent global health problems via support of infectious disease conferences in the "Keystone Symposia Global Health Series."

20 Jul 2012

Scientists develop simple assay to diagnose 'superparasites'

Belgian scientists of the Institute of Tropical Medicine (ITM) in Antwerp, Belgium made a breakthrough in bridging high tech molecular biology research on microbial pathogens and the needs of the poorest of the poor. After sequencing the complete genome of Leishmania donovani (a parasite causing one of the most important tropical diseases after malaria) in hundreds of clinical isolates, they identified a series of mutations specific of 'superparasites' and developed a simple assay that should allow tracking them anywhere.

20 Jul 2012

Donor nation funding for HIV remains at 2008 levels, Kaiser Family Foundation/UNAIDS analysis says

A funding analysis released on Wednesday by the Kaiser Family Foundation (KFF) and UNAIDS found that "funding to fight HIV/AIDS in low- and middle-income countries has remained flat at $7.6 billion," Politico Pro reports.

20 Jul 2012

Scientists identify inhibitors of key enzyme involved in survival of malaria parasite

An international team of scientists, led by researchers from the Department of Pediatrics at the University of California, San Diego School of Medicine, have identified the first reported inhibitors of a key enzyme involved in survival of the parasite responsible for malaria. Their findings, which may provide the basis for anti-malarial drug development, are currently published in the online version of the Journal of Medicinal Chemistry.

20 Jul 2012

BioDiem signs agreement with RMIT to create new non-influenza vaccines

Australian infectious disease therapy and vaccine development company BioDiem Ltd (ASX: BDM) today announced that BioDiem has signed an agreement with The Royal Melbourne Institute of Technology (RMIT) regarding a research program that will investigate the use of BioDiem’s live attenuated influenza virus (LAIV) to create new non-influenza vaccines. Developing the potential of the LAIV technology for new indications is an important part of BioDiem’s strategy, and this research is part of the work towards that goal.

19 Jul 2012

Africa's new partnership for sustainable health development 'makes sense'

With Africa's "emerging position in the global order, ... astute African leaders are striving to ensure that this realignment delivers a new paradigm of partnership for sustainable health development -- a partnership that is led by Africa, for Africans, through African-sourced solutions," UNAIDS Executive Director Michel Sidibe writes in a Huffington Post "Impact Blog" opinion piece.

19 Jul 2012

African leaders reaffirm commitment to eliminate malaria at African Union summit

"African leaders have reaffirmed their commitment to efforts to eliminate malaria, after they were informed that unprecedented success in scaling up malaria control interventions resulted in one-third reduction of malaria deaths in African in the last decade," PANA/Afriquejet reports.

17 Jul 2012

Financial boost to malaria fight would result in beneficial gains

"[A] surge in money for insecticide-treated nets and other interventions" to fight malaria over the past decade has reduced the malaria-related death rate by 26 percent since 2000, and a "new push" to fight the disease, which killed 655,000 people in 2010, would have beneficial results, according to a report set to be released by Ray Chambers, the U.N. special envoy for malaria, an Economist editorial notes.

14 Jul 2012

amfAR analysis examines impact of potential budget sequestration on global health

In this guest post on the Global Health Technologies Coalition's "Breakthroughs" blog, George Fistonich, a research and policy fellow at amfAR, The Foundation for AIDS Research, examines a new amfAR analysis that "outlines the potential effects of budget sequestration on global health programs, using updated figures to reflect recent and accurate estimates."

14 Jul 2012

Donor governments need to conduct more post-market oversight of generic medicines

The WHO and FDA approve drugs to treat malaria, tuberculosis and other diseases in low- and middle-income countries, but "some of the manufacturers, predominantly Chinese and Indian firms, may be knowingly producing" poor quality medicines, according to "the conclusion of my research teams' studies, published this week in the journal Research and Reports in Tropical Medicine," Roger Bate, resident scholar with the American Enterprise Institute and lead author of the studies, writes in a Washington Post opinion piece.

14 Jul 2012

Global Fund hosts first business forum in Bangkok to encourage private-sector support

"The Global Fund to Fight Aids, Tuberculosis and Malaria on Wednesday opened its first business forum in Bangkok to encourage more private-sector support in combating the three epidemics," Thailand's The Nation reports.

14 Jul 2012

Global Fund investigation finds recipient organization in Bangladesh 'misappropriated' some $1.9M in grant funds

"The Global Fund to Fight AIDS, Tuberculosis and Malaria is eyeing the recovery of some $1.89 million 'misappropriated' grant funds following an investigative report on one of its sub-recipients in Bangladesh," the Devex "Development Newswire" blog reports.

13 Jul 2012

AIDS 2012 conference comes at a 'moment of hope'

"A tremendous amount of attention will be focused on AIDS over the next six weeks -- and that's a great thing," as the International AIDS Conference (AIDS 2012) convenes in Washington, D.C., from July 22 to 27, U.S. Global AIDS Coordinator Ambassador Eric Goosby writes in an opinion piece in The Hill.

12 Jul 2012

Many anti-malaria drugs in Africa fake or substandard, reports show

"Many of Africa's anti-malaria drugs are fake or of poor quality, weakening a crucial battle against the world's deadliest disease, a new investigation has found," GlobalPost reports, adding, "Many of the drugs -- even those approved by the World Health Organization -- are Chinese fakes or low-quality variants that failed quality tests, according to two new studies released today."

12 Jul 2012

Malaria News and Research

Latest Malaria News and Research

First results from community HIV testing campaign in Uganda

First Edition: July 24, 2012

BioDiem presents positive findings of their eye disease drug at international conference

New CHAIT initiative on development of novel immunological therapeutic interventions

Cipla, DNDi to develop ARV combination therapy for children with HIV/AIDS

Examining challenges facing Global Fund during its reform

Keystone Symposia on Molecular and Cellular Biology receives Gates Foundation grant

Scientists develop simple assay to diagnose 'superparasites'

Donor nation funding for HIV remains at 2008 levels, Kaiser Family Foundation/UNAIDS analysis says

Scientists identify inhibitors of key enzyme involved in survival of malaria parasite

BioDiem signs agreement with RMIT to create new non-influenza vaccines

Africa's new partnership for sustainable health development 'makes sense'

African leaders reaffirm commitment to eliminate malaria at African Union summit

Financial boost to malaria fight would result in beneficial gains

amfAR analysis examines impact of potential budget sequestration on global health

Donor governments need to conduct more post-market oversight of generic medicines

Global Fund hosts first business forum in Bangkok to encourage private-sector support

Global Fund investigation finds recipient organization in Bangladesh 'misappropriated' some $1.9M in grant funds

AIDS 2012 conference comes at a 'moment of hope'

Many anti-malaria drugs in Africa fake or substandard, reports show

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Malaria News and Research

Latest Malaria News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in